Sydney Adventist Hospital 02 9487 9111

Sydney Adventist Hospital
« View pages

Clinical Specialties

Haematological Cancer Clinical Trials


Randomised double blind placebo controlled phase 3 study of the Bruton's Tyrosine Kinase Inhibitor PCI 32765 (Ibrutinib) in combination with either Bendamustine and Rituximab or Rituximab, Cyclophosphamide , Doxorubicin, Vincristine and Prednisone (RCHOP) in subjects with previously treated indolent NHL

ALLG CLL07 – Recruiting

An Australian, phase II, multicentre, randomised, study investigating safety and efficacy for dose reduced fludarabine, cyclophosphamide and i.v. obinutuzumab (G-FC3) versus oral chlorambucil and i.v. obinutuzumab (G-Clb) in previously untreated, comorbid (CIRS score ≥6), elderly (≥65 years old) patients with chronic lymphocytic leukaemia (CLL)

Back to Top

Sydney Adventist Hospital Clinical Specialties and Services